Evotec (Gottingen) AG
Records under this name other than patents Evotec (Gottingen) AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Evotec (Gottingen) AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,029,323 | Neurturin conjugates for pharmaceutical use Formerly held Lapsed on the fee record Ended May 12, 2023 · USPTO record | Lapsed on the fee record | Ended May 12, 2023 | USPTO record |
| US 9,049,849 | Screening Methods for Compounds Useful for Treating Pancreatic Dysfunction Formerly held Lapsed on the fee record Ended Jun 9, 2019 · High confidence | Lapsed on the fee record | Ended Jun 9, 2019 | High confidence |
| US 8,772,233 | Method for promoting regeneration of pancreatic beta-cells by administering neurturin Formerly held Lapsed on the fee record Ended Jul 8, 2018 · USPTO record | Lapsed on the fee record | Ended Jul 8, 2018 | USPTO record |
| US 8,501,473 | Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome Formerly held Lapsed on the fee record Ended Aug 6, 2017 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2017 | USPTO record |
| US 8,399,408 | Method for treating diabetes using neurturin Formerly held Lapsed on the fee record Ended Mar 19, 2017 · USPTO record | Lapsed on the fee record | Ended Mar 19, 2017 | USPTO record |
| US 7,968,535 | Use of azapaullones for preventing and treating pancreatic autoimmune disorders Formerly held Lapsed on the fee record Ended Jun 28, 2015 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2015 | USPTO record |
| US 7,211,563 | Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis Formerly held Lapsed on the fee record Ended May 1, 2015 · USPTO record | Lapsed on the fee record | Ended May 1, 2015 | USPTO record |